0001179110-12-014966.txt : 20121005 0001179110-12-014966.hdr.sgml : 20121005 20121005193245 ACCESSION NUMBER: 0001179110-12-014966 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121005 FILED AS OF DATE: 20121005 DATE AS OF CHANGE: 20121005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lasowski Juergen CENTRAL INDEX KEY: 0001360376 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 121133227 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2012-10-05 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001360376 Lasowski Juergen C/O ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Corp. Dev & Strategy Common Stock 2012-10-05 4 S 0 5902 90.00 D 31816 D Shares sold pursuant to a 10b5-1 Plan. /s/ Matthew Fust, Attorney-in-fact 2012-10-05